![Aeovian Pharmaceuticals](https://storage.googleapis.com/dealroom-images-production/2f/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzA2LzA4L2MwZjBiMGJiMWEyNzY1MTBkZjBlN2Q4NjM5YmIzMjZi.png)
Aeovian Pharmaceuticals
VerifiedAeovian Pharmaceuticals is a research stage biopharmaceutical company aiming to discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$200—300m (Dealroom.co estimates Mar 2024.)
Walnut Creek California (HQ)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor | $0.0 | round | |
investor | $0.0 | round | |
investor investor investor | $0.0 | round | |
* | $50.0m | Series A | |
Total Funding | 000k |
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about Aeovian Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.